Luis Miguel Pérez Belmonte-rekin lankidetzan egindako argitalpenak (10)

2023

  1. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Adverse outcomes in patients with heart failure admitted for COVID‑19 in association with the use of renin-angiotensin‑aldosterone system inhibitors

    Polish archives of internal medicine, Vol. 132, Núm. 1

  2. Answer to the “Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure” correspondence

    Revista Clinica Espanola

  3. Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain

    Revista Clinica Espanola, Vol. 222, Núm. 5, pp. 255-265

  4. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  5. Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry

    Medicina Clinica, Vol. 159, Núm. 10, pp. 457-464

  6. Reply to “On the heart failure diagnosis. Is it enough with physical examination?”

    Revista Clinica Espanola

  7. Respuesta

    Medicina clinica

2021

  1. Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 76, Núm. 8, pp. E102-E109

  2. Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study

    Internal and Emergency Medicine